Mohammed M. Aboudeif: The Decision-Making Process for Anticoagulation in Stroke
Mohammed M. Aboudeif, Critical Care Registrar at King AbdulAziz University, shared on LinkedIn:
”Timing is often the most critical factor in neurocritical care, especially when balancing the risk of recurrent ischemia against the threat of hemorrhagic transformation.
Standardizing the transition from acute management to long-term prevention is essential for patient safety and clinical excellence.
This visual guide breaks down the decision-making process for Anticoagulation in Stroke, specifically focusing on the initiation of DOACs in patients with Atrial Fibrillation (AF).
Key Takeaways for the Clinical Team:
- The Acute Phase (0-48h): A universal ‘No’ for anticoagulation.
- The focus remains on stabilization, hydration, and DVT prophylaxis (IPC preferred).
Ischemic Stroke and AF
The 1-3-6-12 Rule remains a vital framework for starting DOACs based on stroke severity:
- Day 1: TIA
- Day 3: Mild (NIHSS <8)
- Day 6: Moderate (NIHSS 8-15)
- Day 12: Severe (NIHSS >15)
Hemorrhagic Stroke: A much more conservative approach.
Restarting anticoagulation is generally deferred for 2–4 weeks and reserved for those with high embolic risk (e.g., mechanical valves), requiring careful reassessment of re-bleeding risk.
Standardized protocols like these reduce clinical variability and improve outcomes in the ICU and beyond.”

Stay updated with Hemostasis Today.
-
Apr 18, 2026, 13:04John F. Rossi: St. Vincent’s Medical Center Is Now Recogoized as A Comprehensive Stroke Center
-
Apr 18, 2026, 12:36Michelle Leona Cecil: Honoring the Past While Advancing the Future of Care on World Hemophilia Day
-
Apr 18, 2026, 12:22Maciej Banach: Emerging Triglyceride Targeted Therapies in MASLD and Liver Disease
-
Apr 18, 2026, 12:21Sarah Richardson: I’m Proud to Advocate for My Hemo Hero, for Myself, and for The Entire Community
-
Apr 18, 2026, 11:33Standing Together for Patients with Bleeding Disorders – ISTH
-
Apr 18, 2026, 11:21Gianluca Franceschini: Immersive Virtual Reality in Preoperative Care
-
Apr 18, 2026, 10:58Jean Jacques Kiladjian: Honored to Join the HST EHA Session at the Taiwan Annual Meeting
-
Apr 18, 2026, 10:49Advancing Diagnosis to Improve Lives in Hemophilia – WFH
-
Apr 18, 2026, 10:40Akshat Jain: Improving Treatment and Access for Patients with Bleeding Disorders